SUPERSTAR: Aspiration vs. Stent Retriever in Anterior Circulation LVO (NCT07555977) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
SUPERSTAR: Aspiration vs. Stent Retriever in Anterior Circulation LVO
708 participantsStarted 2026-05-01
Plain-language summary
This is a multicenter, open-label, blinded-endpoint, randomized controlled trial comparing super large bore catheter aspiration versus stent retriever thrombectomy as the first-line technique for anterior circulation large vessel occlusion in acute ischemic stroke. Eligible patients with acute ischemic stroke due to internal carotid artery intracranial segment and/or middle cerebral artery M1 occlusion will be randomized 1:1 to receive either aspiration using a super large bore catheter (inner diameter β₯0.080 inch) or stent retriever thrombectomy (allowing balloon guiding catheters or intermediate catheters with inner diameter \<0.080 inch). The primary outcome is the ordinal modified Rankin Scale score at 90 days post-procedure. Key secondary outcomes include the proportion of patients with mRS 0-2 at 90 days, change in NIHSS at 24 hours and 7 days, and various angiographic and safety endpoints. The trial plans to enroll 708 patients across approximately 30 centers in China. The total study duration is 24-36 months, with each patient participating for 3 months.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
β. Age β₯ 18 years;
β. Clinically diagnosed with acute ischemic stroke, and pre-procedure imaging confirms that the culprit vessel is occlusion of the intracranial segment of the internal carotid artery and/or the middle cerebral artery M1 segment;
β. Pre-stroke modified Rankin Scale (mRS) score of 0-1;
β. Baseline National Institutes of Health Stroke Scale (NIHSS) score β₯ 6;
β. Alberta Stroke Program Early CT Score (ASPECTS) β₯ 3;
β. Time from symptom onset to initiation of endovascular treatment (arterial puncture) \< 24 hours; symptom onset time is defined as the "last known well" time;
β. Intravenous thrombolysis and/or mechanical thrombectomy are performed according to local guidelines, and intravenous thrombolysis does not delay mechanical thrombectomy;
β. Written informed consent is obtained from the patient or a family member.
Exclusion criteria
β
What they're measuring
1
Ordinal modified Rankin Scale score
Timeframe: 90 days (Β±7 days) post-procedure
Trial details
NCT IDNCT07555977
SponsorShanghai Jiao Tong University Affiliated Sixth People's Hospital